Lucy Scientific Discovery to Acquire Wesana Health
Lucy Scientific Discovery Signs Definitive Agreement To Acquire Wesana Health; No Financial Terms Disclosed
Lucy Scientific Discovery CEO Chris McElvany and Wesana CEO Dan Carcillo joined Steve Darling from Proactive to share news the company has signed a definitive agreement to purchase the assets of Wesan
High Times And Lucy Scientific Discovery Launching Amanita Muscaria Mushrooms Product
Psychedelics producer Lucy Scientific Discovery Inc. (NASDAQ:LSDI) is launching a new brand of products containing unscheduled psychoactive compounds, soon available for sale in the U.S. and all other
Lucy Scientific Discovery Shares Rise After Announcement of New Psychoactive Drugs
By Bob Henderson Lucy Scientific Discovery Inc. shares were up about 6.5% to $1.48 on Thursday after the company announced a new line of psychoactive products in partnership with High Times Holding C
Lucy Scientific Discovery, High Times Team Up to Launch New Products
12:01 PM EDT, 03/23/2023 (MT Newswires) -- Lucy Scientific Discovery (LSDI) said Thursday it is launching a new product line of unscheduled psychoactive compounds in the US and other countries in part
Lucy Scientific Discovery Announces Partnership With High Times to Develop and Distribute a New Line of Psychoactive Products
WKHS, OPEN and BILI Are Among Pre Market Gainers
Sector Update: Health Care Stocks Lifted With Broader Markets
04:09 PM EDT, 03/21/2023 (MT Newswires) -- Health care stocks added to earlier gains, with the NYSE Health Care Index climbing 0.7% and the Health Care Select Sector SPDR Fund (XLV) rising 0.6%. The
Top Midday Gainers
02:21 PM EDT, 03/21/2023 (MT Newswires) -- First Republic Bank (FRC) rebounded Tuesday afternoon, recouping a portion of its 85% decline since March 10, after US Treasury Secretary Janet Yellen Tuesda
Sector Update: Health Care Stocks Still Struggling for Firm Direction Tuesday Afternoon
01:59 PM EDT, 03/21/2023 (MT Newswires) -- Health care stocks were edging higher Tuesday afternoon, with the NYSE Health Care Index gaining 0.2% and the Health Care Select Sector SPDR Fund (XLV) down